High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-017-1566-1
Abstract: Arterial and venous complications are major causes of morbidity and mortality in myeloproliferative neoplasms (MPNs). MPNs patients, frequently receive heparin. Heparin-induced thrombocytopenia (HIT) is a rare but potentially life-threatening complication resulting in a severe acquired… read more here.
Keywords: heparin treatment; v617f mutation; induced thrombocytopenia; heparin induced ... See more keywords
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14902
Abstract: Abstract Most severe manifestations of COVID‐19 cases, such as multiple organ failure and death, have been linked to coagulation dysfunction markers, such as platelet reduction and increases in prothrombin time, fibrin degradation products and, mainly,… read more here.
Keywords: antiarrhythmic effects; covid patients; anticoagulant antiarrhythmic; heparin treatment ... See more keywords